- Home
- KNSA vs TTMI Comparison
KNSA vs TTMI Comparison
Compare KNSA & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- TTMI
- Stock Information
- Founded
- KNSA 2015
- TTMI 1978
- Country
- KNSA United Kingdom
- TTMI United States
- Employees
- KNSA N/A
- TTMI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- TTMI Electrical Products
- Sector
- KNSA Health Care
- TTMI Technology
- Exchange
- KNSA Nasdaq
- TTMI Nasdaq
- Market Cap
- KNSA 2.1B
- TTMI 1.9B
- IPO Year
- KNSA 2018
- TTMI 2000
- Fundamental
- Price
- KNSA $27.53
- TTMI $41.05
- Analyst Decision
- KNSA Strong Buy
- TTMI Strong Buy
- Analyst Count
- KNSA 5
- TTMI 5
- Target Price
- KNSA $38.80
- TTMI $36.80
- AVG Volume (30 Days)
- KNSA 1.1M
- TTMI 1.7M
- Earning Date
- KNSA 07-22-2025
- TTMI 07-30-2025
- Dividend Yield
- KNSA N/A
- TTMI N/A
- EPS Growth
- KNSA N/A
- TTMI N/A
- EPS
- KNSA N/A
- TTMI 0.75
- Revenue
- KNSA $481,166,000.00
- TTMI $2,521,308,000.00
- Revenue This Year
- KNSA $37.21
- TTMI $11.55
- Revenue Next Year
- KNSA $5.32
- TTMI $5.54
- P/E Ratio
- KNSA N/A
- TTMI $54.62
- Revenue Growth
- KNSA 59.45
- TTMI 11.65
- 52 Week Low
- KNSA $17.38
- TTMI $15.78
- 52 Week High
- KNSA $30.69
- TTMI $41.54
- Technical
- Relative Strength Index (RSI)
- KNSA 54.29
- TTMI 82.09
- Support Level
- KNSA $27.62
- TTMI $35.52
- Resistance Level
- KNSA $29.23
- TTMI $40.57
- Average True Range (ATR)
- KNSA 1.03
- TTMI 1.35
- MACD
- KNSA -0.21
- TTMI 0.13
- Stochastic Oscillator
- KNSA 46.99
- TTMI 95.26
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.